SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
biotech firesales
An SI Board Since August 2001
Posts SubjectMarks Bans
3661 167 0
Emcee:  dalroi Type:  Moderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2811TSPT closed near the low off 42.5% 1:36AM Transcept Pharma expects Complete ResIan@SI-7/13/2011
2810AFFX down ~18% on Q2 earnings guidance.idos-7/7/2011
2809FCSC -25%, which is absolutely unsurprising for the reason mentioned in siliconiDewDiligence_on_SI-6/27/2011
2808PTIE follows up Friday's drop with another -36%tnsaf-6/27/2011
2807Hi Tuck. I think I had drrx in the charity portfolio too, will have to go look. fred hayes-6/24/2011
2806Pain Therapeutics (PTEI) and DuRect (DRRX) both off around 35% as their formulattuck-6/24/2011
2805EXEL almost 20 % Dow Jones says on side effects concerns: CHICAGO (Dow Jones)--sjemmeri-6/6/2011
2804VVUS It's not down by much, and looked pretty feisty after noon or so. Dontom pope-6/3/2011
2803>> Nobody in their right mind ever gave Contrave a chance, other than thatscaram(o)uche-6/3/2011
2802CLDX 15% pre-market on secondary @$3.15.biofisher-5/18/2011
2801Wrong explanation, IMO.DewDiligence_on_SI-4/29/2011
2800REGN, on news that cheap avastin is effective. (subtitled "duh!")scaram(o)uche14/29/2011
2799Adeona (AEN) off 20% on poor data, and Rexahn (RXII) off 18% on a poor financingtuck-4/15/2011
2798<i> Luckily I didn't short sell :) </i> ouch, at least you are mopgcw-4/1/2011
2797yeah what would they think about that :-)dalroi-4/1/2011
2796This was telegraphed. They had announced in November data by early 2011. When itrkrw-3/31/2011
2795Omeros (OMER) off about 42% AH as its pain drug fails in p3. Cheers, Tucktuck-3/31/2011
2794Rexahn (RNN) off about 23% on a dilutive financing. In light of the likely scamtuck-3/28/2011
2793I don’t follow the company closely but I recall some PR’s with wild and exaggeraDewDiligence_on_SI-3/24/2011
2792Why do you think it's a scam? The lung drug concept seems pretty straightforrkrw-3/24/2011
2791I’m pretty sure it’s a scam (eom).DewDiligence_on_SI-3/24/2011
2790MediciNova (MNOV) off 24% on warrant laden financing. I think it had a rather btuck-3/24/2011
2789XOMA again on a PhII failure. About 35%. XOMA Ltd. (XOMA) After Hours TradingIan@SI-3/22/2011
2788American Oriental Bioengineering (AOB) is off 20% following earnings and a downgtuck-3/15/2011
2787SIGA, priced for a profit and some managerial talk of a government contract on ttuck-3/10/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News